查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1881705

口腔癌快速检测试剂盒市场－全球产业规模、份额、趋势、机会和预测，按类型、最终用户、地区和竞争格局划分，2020-2030年预测

Oral Cancer Rapid Test Kit Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End user, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年全球口腔癌快速检测试剂盒市场规模为10.1259亿美元，预计2030年将以4.3%的复合年增长率成长至13.0359亿美元。口腔癌快速检测试剂盒是一种非侵入性诊断工具，旨在快速识别潜在的口腔癌病例，主要用于即时检测，以促进早期发现。市场扩张的根本驱动因素是全球口腔癌发生率的不断上升以及人们对早期诊断和定期筛检益处的认识不断提高。

市场概览
预测期 2026-2030
2024年市场规模 10.1259亿美元
2030年市场规模 13.0359亿美元
2025-2030年复合年增长率 4.3%
成长最快的细分市场 晶片实验室
最大的市场 北美洲

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球口腔癌快速检测试剂盒市场展望

  • 市场规模及预测
    • 按价值
  • 市占率及预测
    • 依类型（Onc Alert 口腔癌实验室检测、晶片实验室检测、Insilixa 检测、Prevo-Check 检测）
    • 按最终使用者（医院和诊所、门诊中心、其他）
    • 按地区
    • 按公司（2024 年）
  • 市场地图

第六章：北美口腔癌快速检测试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲口腔癌快速检测试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区口腔癌快速检测试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲口腔癌快速检测试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿联酋
    • 南非

第十章：南美洲口腔癌快速检测试剂盒市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章：市场动态

  • 司机
  • 挑战

第十二章：市场趋势与发展

  • 併购（如有）
  • 产品发布（如有）
  • 最新进展

第十三章：全球口腔癌快速检测试剂盒市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商议价能力
  • 顾客的力量
  • 替代产品的威胁

第十五章：竞争格局

  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • GRAIL, LLC
  • Henry Schein, Inc.
  • Quest Diagnostics Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
  • Trinity Biotech plc
  • Viome Life Sciences, Inc.

第十六章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 21727

The Global Oral Cancer Rapid Test Kit Market, valued at USD 1012.59 Million in 2024, is projected to experience a CAGR of 4.3% to reach USD 1303.59 Million by 2030. Oral Cancer Rapid Test Kits are non-invasive diagnostic tools designed for the swift identification of potential oral cancer cases, primarily employed in point-of-care settings to facilitate early detection. The market's expansion is fundamentally driven by the escalating global incidence of oral cancer and increasing awareness regarding the benefits of early diagnosis and regular screening programs.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1012.59 Million
Market Size 2030USD 1303.59 Million
CAGR 2025-20304.3%
Fastest Growing SegmentLab on Chip
Largest MarketNorth America

Key Market Drivers

The escalating global incidence of oral cancer fundamentally drives the Oral Cancer Rapid Test Kit Market, necessitating accessible and efficient diagnostic tools. Early detection is critical for improving patient outcomes, as oral cancer often presents in advanced stages with poorer prognoses. For example, according to Cancer Research UK, in 2022, there were 389,846 new cases of mouth and oral cancer globally. This substantial annual caseload underscores the urgent need for widespread early screening. Rapid test kits are ideally positioned to meet this demand, enabling timely identification in diverse healthcare settings and facilitating prompt intervention. The rising global prevalence of oral cancer sustains the imperative for proactive screening measures that these rapid diagnostic solutions can effectively support.

Key Market Challenges

The limited public and professional awareness regarding oral cancer risk factors, the importance of early detection, and the availability of rapid testing options significantly impedes the growth of the Global Oral Cancer Rapid Test Kit Market. This challenge directly restricts the adoption and utilization of these diagnostic tools. When both the general public and healthcare professionals lack comprehensive education on oral cancer's subtle initial signs and the critical benefits of early screening, the demand for rapid test kits remains subdued.

Key Market Trends

The expansion of at-home testing solutions represents a pivotal trend, broadening access to oral cancer screening beyond traditional clinical settings. This trend addresses the demand for convenient diagnostic tools, empowering individuals to undertake preliminary screening privately and efficiently. For example, the U. S. Centers for Disease Control and Prevention reported that cancer screening rates declined by 15-2% since 2020, highlighting the substantial need for accessible home-based alternatives.

Key Market Players

  • Abbott Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Co.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • GRAIL, LLC
  • Henry Schein, Inc.
  • Quest Diagnostics Inc.
  • Quidel Corp.
  • Siemens Healthineers AG
  • Trinity Biotech plc
  • Viome Life Sciences, Inc.

Report Scope:

In this report, the Global Oral Cancer Rapid Test Kit Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Cancer Rapid Test Kit Market, By Type:

  • Onc Alert Oral Cancer LAB
  • Lab on Chip
  • Insilixa Test
  • Prevo- Check

Oral Cancer Rapid Test Kit Market, By End user:

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Oral Cancer Rapid Test Kit Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Oral Cancer Rapid Test Kit Market.

Available Customizations:

Global Oral Cancer Rapid Test Kit Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oral Cancer Rapid Test Kit Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Onc Alert Oral Cancer LAB, Lab on Chip, Insilixa Test, Prevo- Check)
    • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Oral Cancer Rapid Test Kit Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By End user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Oral Cancer Rapid Test Kit Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End user
    • 6.3.2. Canada Oral Cancer Rapid Test Kit Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End user
    • 6.3.3. Mexico Oral Cancer Rapid Test Kit Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End user

7. Europe Oral Cancer Rapid Test Kit Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By End user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End user
    • 7.3.2. France Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End user
    • 7.3.3. United Kingdom Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End user
    • 7.3.4. Italy Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End user
    • 7.3.5. Spain Oral Cancer Rapid Test Kit Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End user

8. Asia Pacific Oral Cancer Rapid Test Kit Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By End user
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End user
    • 8.3.2. India Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End user
    • 8.3.3. Japan Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End user
    • 8.3.4. South Korea Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End user
    • 8.3.5. Australia Oral Cancer Rapid Test Kit Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End user

9. Middle East & Africa Oral Cancer Rapid Test Kit Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By End user
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Oral Cancer Rapid Test Kit Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End user
    • 9.3.2. UAE Oral Cancer Rapid Test Kit Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End user
    • 9.3.3. South Africa Oral Cancer Rapid Test Kit Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End user

10. South America Oral Cancer Rapid Test Kit Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By End user
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Oral Cancer Rapid Test Kit Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End user
    • 10.3.2. Colombia Oral Cancer Rapid Test Kit Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End user
    • 10.3.3. Argentina Oral Cancer Rapid Test Kit Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Oral Cancer Rapid Test Kit Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Thermo Fisher Scientific Inc.
  • 15.3. F. Hoffmann-La Roche AG
  • 15.4. Beckman Coulter, Inc.
  • 15.5. Becton, Dickinson and Co.
  • 15.6. Bio-Rad Laboratories, Inc.
  • 15.7. Danaher Corp.
  • 15.8. GRAIL, LLC
  • 15.9. Henry Schein, Inc.
  • 15.10. Quest Diagnostics Inc.
  • 15.11. Quidel Corp.
  • 15.12. Siemens Healthineers AG
  • 15.13. Trinity Biotech plc
  • 15.14. Viome Life Sciences, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer